Therefore, we hypothesized that the combination of ABT-263 and fenretinide could also induce efficient cell death in HNSCC, which would suggest that fenretinide could be an alternative NOXA inducer. This evidence concerns the gene PMAIP1 and head and neck squamous cell carcinoma.